SCHEMBL8360883

SCHEMBL8360883

COC(=O)c1ccccc1CN(C1CCCN(C(=O)OC(C)(C)C)C1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 4/20 0.44
RORC P51449 1/20 0.43
NR1D1 P20393 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
AHCY P23526 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
KAT7 O95251 1/20 0.39
KAT8 Q9H7Z6 1/20 0.39
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
MMP1 P03956 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360870 0.86 NR1D1 (0.48) STSRORCNR1D1KMT2AMEN1
SCHEMBL8360879 0.85 JAK2 (0.51) STSRORCNR1D1KMT2AMEN1
SCHEMBL2331964 0.79 ALDH1A1 (0.51) NR1D1KMT2AMEN1PSEN1PSEN2
SCHEMBL2337474 0.78 MEN1 (0.44) STSNR1D1KMT2AMEN1AHCY
SCHEMBL2337471 0.78 MEN1 (0.44) STSNR1D1KMT2AMEN1AHCY
SCHEMBL8363938 0.78 CNR1 (0.46) KMT2AMEN1KDM4EHSD17B10SMN1; SMN2
SCHEMBL8360876 0.78 KCNA5 (0.55) STSRORCKMT2AMEN1ALDH1A1
SCHEMBL8363935 0.77 MEN1 (0.46) RORCKMT2AMEN1PSEN1PSEN2
SCHEMBL8360877 0.77 JAK2 (0.52) STSRORCKMT2AMEN1ALDH1A1
SCHEMBL8363933 0.77 KMT2A (0.54) RORCKMT2AMEN1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003013527-A1 SULFONAMIDE DERIVATIVES AS GAMMA SECRETASE INHIBITORS SCHERING CORPORATION (US) 2003-02-20 WO disclosed